EdgarLookup

Brookfield DTLA Fund Office Trust Investor Inc. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Brookfield DTLA Fund Office Trust Investor Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
-70%
Profit Margin
Net income ÷ revenue
-2.1%
Return on Assets
Net income ÷ assets
+1.5%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2022 Dec 31, 2022 $75.63M Mar 31, 2023
FY2022 Sep 30, 2022 $74.53M Mar 31, 2023
FY2022 Jun 30, 2022 $73.72M Mar 31, 2023
FY2022 Mar 31, 2022 $72.02M Mar 31, 2023
FY2022 Dec 31, 2021 $76.08M Mar 31, 2023
FY2022 Sep 30, 2021 $68.82M Mar 31, 2023
FY2022 Jun 30, 2021 $69.21M Mar 31, 2023
FY2022 Mar 31, 2021 $69.69M Mar 31, 2023
FY2021 Dec 31, 2020 $70.58M Mar 24, 2022
FY2021 Sep 30, 2020 $70.59M Mar 24, 2022

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2022 Dec 31, 2022 ($52.93M) Mar 31, 2023
FY2022 Sep 30, 2022 ($206.36M) Mar 31, 2023
FY2022 Jun 30, 2022 ($8.32M) Mar 31, 2023
FY2022 Mar 31, 2022 ($15.19M) Mar 31, 2023
FY2022 Dec 31, 2021 ($13.70M) Mar 31, 2023
FY2022 Sep 30, 2021 ($49.49M) Mar 31, 2023
FY2022 Jun 30, 2021 ($15.70M) Mar 31, 2023
FY2022 Mar 31, 2021 ($42.12M) Mar 31, 2023
FY2021 Dec 31, 2020 ($48.61M) Mar 24, 2022
FY2021 Sep 30, 2020 ($14.35M) Mar 24, 2022

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2022 Dec 31, 2022 $39.83M Mar 31, 2023
FY2022 Dec 31, 2021 $61.65M Mar 31, 2023
FY2022 Dec 31, 2020 $52.95M Mar 31, 2023
FY2021 Dec 31, 2019 $39.79M Mar 24, 2022
FY2020 Dec 31, 2018 $17.39M Mar 25, 2021
FY2019 Dec 31, 2017 $31.79M Mar 26, 2020
FY2018 Dec 31, 2016 $35.83M Apr 1, 2019
FY2017 Dec 31, 2015 $29.99M Mar 27, 2018
FY2016 Dec 31, 2014 $22.96M Mar 20, 2017
FY2015 Dec 31, 2013 ($2.21M) Mar 28, 2016

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2022 Dec 31, 2022 $2.54B Mar 31, 2023
FY2022 Dec 31, 2021 $2.72B Mar 31, 2023
FY2021 Dec 31, 2020 $2.82B Mar 24, 2022
FY2020 Dec 31, 2019 $2.83B Mar 25, 2021
FY2019 Dec 31, 2018 $2.80B Mar 26, 2020
FY2018 Dec 31, 2017 $2.75B Apr 1, 2019
FY2017 Dec 31, 2016 $2.77B Mar 27, 2018
FY2016 Dec 31, 2015 $2.80B Mar 20, 2017
FY2015 Dec 31, 2014 $2.87B Mar 28, 2016
FY2014 Dec 31, 2013 $2.95B Mar 31, 2015

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2022 Dec 31, 2022 $2.36B Mar 31, 2023
FY2022 Dec 31, 2021 $2.34B Mar 31, 2023
FY2021 Dec 31, 2020 $2.34B Mar 24, 2022
FY2020 Dec 31, 2019 $2.29B Mar 25, 2021
FY2019 Dec 31, 2018 $2.22B Mar 26, 2020
FY2018 Dec 31, 2017 $2.10B Apr 1, 2019
FY2017 Dec 31, 2016 $2.20B Mar 27, 2018
FY2016 Dec 31, 2015 $2.26B Mar 20, 2017
FY2015 Dec 31, 2014 $2.23B Mar 28, 2016
FY2014 Dec 31, 2013 $2.03B Mar 31, 2015

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2013 Dec 31, 2013 $0 Apr 8, 2014
FY2013 Dec 31, 2012 $508.70M Apr 8, 2014

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2022 Dec 31, 2022 ($1.17B) Mar 31, 2023
FY2022 Dec 31, 2021 ($865.93M) Mar 31, 2023
FY2021 Dec 31, 2020 ($726.37M) Mar 24, 2022
FY2020 Dec 31, 2019 ($499.79M) Mar 25, 2021
FY2019 Dec 31, 2018 ($385.16M) Mar 26, 2020
FY2018 Dec 31, 2017 ($256.88M) Apr 1, 2019
FY2017 Dec 31, 2016 ($215.26M) Mar 27, 2018
FY2016 Dec 31, 2015 ($177.88M) Mar 20, 2017
FY2015 Dec 31, 2014 ($137.34M) Mar 28, 2016
FY2014 Dec 31, 2013 ($89.18M) Mar 31, 2015

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2022 Dec 31, 2022 $23.52M Mar 31, 2023
FY2022 Dec 31, 2021 $38.90M Mar 31, 2023
FY2022 Dec 31, 2020 $37.39M Mar 31, 2023
FY2022 Dec 31, 2019 $33.96M Mar 31, 2023
FY2021 Dec 31, 2018 $80.42M Mar 24, 2022
FY2020 Dec 31, 2017 $31.96M Mar 25, 2021
FY2019 Dec 31, 2016 $30.30M Mar 26, 2020
FY2018 Dec 31, 2015 $53.74M Apr 1, 2019
FY2017 Dec 31, 2014 $125.00M Mar 27, 2018
FY2016 Dec 31, 2013 $196.07M Mar 20, 2017

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2022 Dec 31, 2022 $2.28B Mar 31, 2023
FY2022 Dec 31, 2021 $2.26B Mar 31, 2023
FY2021 Dec 31, 2020 $2.24B Mar 24, 2022
FY2020 Dec 31, 2019 $2.20B Mar 25, 2021
FY2019 Dec 31, 2018 $2.14B Mar 26, 2020
FY2018 Dec 31, 2017 $1.99B Apr 1, 2019
FY2017 Dec 31, 2016 $2.08B Mar 27, 2018
FY2016 Dec 31, 2015 $2.11B Mar 20, 2017
FY2015 Dec 31, 2014 $2.11B Mar 28, 2016
FY2014 Dec 31, 2013 $1.89B Mar 31, 2015

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2022 Dec 31, 2022 1,000 Mar 31, 2023
FY2022 Dec 31, 2021 1,000 Mar 31, 2023
FY2021 Dec 31, 2020 1,000 Mar 24, 2022
FY2020 Dec 31, 2019 1,000 Mar 25, 2021
FY2019 Dec 31, 2018 1,000 Mar 26, 2020
FY2018 Dec 31, 2017 1,000 Apr 1, 2019
FY2017 Dec 31, 2016 1,000 Mar 27, 2018
FY2016 Dec 31, 2015 1,000 Mar 20, 2017
FY2015 Dec 31, 2014 1,000 Mar 28, 2016
FY2014 Dec 31, 2013 1,000 Mar 31, 2015